amitava banerjee
@amitava-immuno.bsky.social
@cshlnews.bsky.social postdoc with @hannahvmeyer.bsky.social and Saket Navlakha • How your T cells know it's you • Develops immuno tools named after Gotham characters: github.com/meyer-lab-cshl/BATMAN 🦇 • they/he 🏳️🌈🏳️⚧️
Pinned
Got new #TCR-pMHC data to send our way into BATCAVE? Wanna try BATMAN to predict targets of your #TCR? We would love to hear from you!
💽Database+codes: github.com/meyer-lab-cs...
💻BATMAN software + tutorials: github.com/meyer-lab-cs...
🦇Lets decode TCR-pMHC logic, one mutation at a time🦇
💽Database+codes: github.com/meyer-lab-cs...
💻BATMAN software + tutorials: github.com/meyer-lab-cs...
🦇Lets decode TCR-pMHC logic, one mutation at a time🦇
Authoritative review from The one and only @ghoshonthemove.bsky.social ☺️on her doctoral work on NSCLC 🫁 @mcgillgci.bsky.social
portlandpress.com/biochemsoctr...
Need to stay tuned to see if these mutations can generate targetable neoantigens in tricky low-TMB cancers
portlandpress.com/biochemsoctr...
Need to stay tuned to see if these mutations can generate targetable neoantigens in tricky low-TMB cancers
Mechanistic insights into MET exon 14 skipping mutations and their role in tumor progression
The MET receptor tyrosine kinase is a pivotal regulator of cellular survival, motility, and proliferation. Mutations leading to skipping of exon 14 (METΔex14) within the juxtamembrane domain of MET im...
portlandpress.com
September 10, 2025 at 12:58 PM
Authoritative review from The one and only @ghoshonthemove.bsky.social ☺️on her doctoral work on NSCLC 🫁 @mcgillgci.bsky.social
portlandpress.com/biochemsoctr...
Need to stay tuned to see if these mutations can generate targetable neoantigens in tricky low-TMB cancers
portlandpress.com/biochemsoctr...
Need to stay tuned to see if these mutations can generate targetable neoantigens in tricky low-TMB cancers
Our latest work featured in The Scientist! Sneha Khedkar Did a great job in summarizing the work accessibly while retaining some of the fine details. Happy reading!
www.the-scientist.com/batman-signa...
www.the-scientist.com/batman-signa...
BATMAN Signals T Cell Receptor Crossreactivity
A new AI tool that models how variations in peptides change T cell receptor binding could help design immunotherapies with fewer off-target effects.
www.the-scientist.com
July 27, 2025 at 1:05 AM
Our latest work featured in The Scientist! Sneha Khedkar Did a great job in summarizing the work accessibly while retaining some of the fine details. Happy reading!
www.the-scientist.com/batman-signa...
www.the-scientist.com/batman-signa...
@cshlnews.bsky.social @samueldiamond.bsky.social Thanks for the feature 🧡
Developed by CSHL researchers, BATMAN is a new AI model trained to predict which cancer markers immune cells will target—while avoiding healthy ones. This could help scientists develop safer, more effective therapies for cancer & all human illnesses. www.cshl.edu/batman-bring...
BATMAN brings TCR therapy out of the shadows | Cold Spring Harbor Laboratory
Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to one day become a universal cancer treatment. But there are risks. Similarit...
www.cshl.edu
July 25, 2025 at 5:33 PM
@cshlnews.bsky.social @samueldiamond.bsky.social Thanks for the feature 🧡
Got new #TCR-pMHC data to send our way into BATCAVE? Wanna try BATMAN to predict targets of your #TCR? We would love to hear from you!
💽Database+codes: github.com/meyer-lab-cs...
💻BATMAN software + tutorials: github.com/meyer-lab-cs...
🦇Lets decode TCR-pMHC logic, one mutation at a time🦇
💽Database+codes: github.com/meyer-lab-cs...
💻BATMAN software + tutorials: github.com/meyer-lab-cs...
🦇Lets decode TCR-pMHC logic, one mutation at a time🦇
July 25, 2025 at 3:12 PM
Got new #TCR-pMHC data to send our way into BATCAVE? Wanna try BATMAN to predict targets of your #TCR? We would love to hear from you!
💽Database+codes: github.com/meyer-lab-cs...
💻BATMAN software + tutorials: github.com/meyer-lab-cs...
🦇Lets decode TCR-pMHC logic, one mutation at a time🦇
💽Database+codes: github.com/meyer-lab-cs...
💻BATMAN software + tutorials: github.com/meyer-lab-cs...
🦇Lets decode TCR-pMHC logic, one mutation at a time🦇
First postdoc paper with @hannahvmeyer.bsky.social on #TCR cross-reactivity database & modeling out now in Cell Systems: doi.org/10.1016/j.ce...
BATCAVE database + Paper codes: github.com/meyer-lab-cs...
BATMAN + Tutorial Notebooks: github.com/meyer-lab-cs...
#ImmunoSky #T-cells #CancerImmunology
BATCAVE database + Paper codes: github.com/meyer-lab-cs...
BATMAN + Tutorial Notebooks: github.com/meyer-lab-cs...
#ImmunoSky #T-cells #CancerImmunology
July 25, 2025 at 2:59 PM
First postdoc paper with @hannahvmeyer.bsky.social on #TCR cross-reactivity database & modeling out now in Cell Systems: doi.org/10.1016/j.ce...
BATCAVE database + Paper codes: github.com/meyer-lab-cs...
BATMAN + Tutorial Notebooks: github.com/meyer-lab-cs...
#ImmunoSky #T-cells #CancerImmunology
BATCAVE database + Paper codes: github.com/meyer-lab-cs...
BATMAN + Tutorial Notebooks: github.com/meyer-lab-cs...
#ImmunoSky #T-cells #CancerImmunology
Thrilled to visit @hhmijanelia.bsky.social to share how fine mapping of large-scale TCR-antigen interaction networks are revealing design principles and physical biology of the adaptive immune system! #ImmunoSky
📣 Students + postdocs in theoretical biophysics 👉 Join us in October to present your research, engage in lively discussions, and network with peers.
✈️ Hotel, meals, & travel fully covered
🔗 Apply by June 10 ➡️ janelia.news/THB25
@hhmi.org
@allysonsgro.bsky.social
@zamakany.bsky.social
✈️ Hotel, meals, & travel fully covered
🔗 Apply by June 10 ➡️ janelia.news/THB25
@hhmi.org
@allysonsgro.bsky.social
@zamakany.bsky.social
July 16, 2025 at 10:03 PM
Thrilled to visit @hhmijanelia.bsky.social to share how fine mapping of large-scale TCR-antigen interaction networks are revealing design principles and physical biology of the adaptive immune system! #ImmunoSky
Catch our latest work on modeling TCR cross-reactivity here
Ready to start the #ATCR25 meeting celebrating 10 years of the AUDACIS consortium with this amazing line-up of speakers!
May 27, 2025 at 3:32 PM
Catch our latest work on modeling TCR cross-reactivity here
Nice day to start the CSHL #cshlsysimm @cshlmeetings.bsky.social Meeting
April 22, 2025 at 11:03 PM
Nice day to start the CSHL #cshlsysimm @cshlmeetings.bsky.social Meeting
Starting tomorrow with an exciting speaker lineup! Catch up with our work on thymic negative selection and T cell cross-reactivity! @cshlmeetings.bsky.social
Looking forward to discussing research in #systems_immunology at CSHL (meetings.cshl.edu/meetings.asp...)
April 21, 2025 at 9:31 PM
Starting tomorrow with an exciting speaker lineup! Catch up with our work on thymic negative selection and T cell cross-reactivity! @cshlmeetings.bsky.social
Catch up with some of my latest TCR work, to be presented by my PI, Dr. Hannah Meyer
#Abstract submission deadline for #ATCR2025 is this Friday!
We are again very grateful to have such a strong lineup of #Tcell-receptor experts joining us in Antwerp. Currently at 80% capacity so do not wait to register.
www.uantwerpen.be/atcr2025
We are again very grateful to have such a strong lineup of #Tcell-receptor experts joining us in Antwerp. Currently at 80% capacity so do not wait to register.
www.uantwerpen.be/atcr2025
April 16, 2025 at 6:16 PM
Catch up with some of my latest TCR work, to be presented by my PI, Dr. Hannah Meyer
Reposted by amitava banerjee
Comprehensive epitope mutational scan database enables accurate T cell receptor cross-reactivity prediction [updated]
BATCAVE & BATMAN predict TCR activation, off-target effects, & polyclonal responses.
BATCAVE & BATMAN predict TCR activation, off-target effects, & polyclonal responses.
February 21, 2025 at 8:54 PM
Comprehensive epitope mutational scan database enables accurate T cell receptor cross-reactivity prediction [updated]
BATCAVE & BATMAN predict TCR activation, off-target effects, & polyclonal responses.
BATCAVE & BATMAN predict TCR activation, off-target effects, & polyclonal responses.